Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
The Emory Clinic
mi
from
Atlanta, GA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Gastroenterology Associates
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
NY Scientific
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Englewood Hospital and Medical Center
mi
from
Englewood, NJ
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Drug Trials America
mi
from
Hartsdale, NY
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Harmony Medical Research Institute, Inc
mi
from
Hialeah, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
UCSD Medical Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Great Lakes Gastroenterology
mi
from
Mentor, OH
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Lenox Hill Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Concorde Medical Group
mi
from
New York, NY
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
DiGiovanna Institute for Medical Education and Research
mi
from
North Massapequa, NY
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Digestive Health Specialists of Tyler
mi
from
Tyler, TX
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
PMG Research of Winston-Salem
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Study of Pemetrexed + Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With Tyrosine Kinase Inhibitor- (TKI)-Resistant Epidermal Growth Factor Receptor- (EGFR)-Mutated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-789/KEYNOTE-789)
Status: Enrolling, Phase III
Updated: 12/31/1969
UT Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Hamzavi Dermatology
mi
from
Fort Gratiot, MI
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Dermatology Specialist
mi
from
Louisville, KY
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Dermatologic Surgery Specialists, Inc.
mi
from
Macon, GA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Austin Institute for Clinical Research, Inc.
mi
from
Pflugerville, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Oregon Dermatology & Research Center
mi
from
Portland, OR
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology Clinical Trial
Morning Bright Light to Improve Sleep Quality in Veterans
Status: Enrolling
Updated: 12/31/1969
VA Portland Health Care System
mi
from
Portland, OR
Click here to add this to my saved trials
Premature Ejaculation Clinical Trial
PSD502 in Subjects With Premature Ejaculation
Status: Enrolling, Phase II
Updated: 12/31/1969
Achieve Clinical Research
mi
from
Birmingham, AL
Click here to add this to my saved trials
Premature Ejaculation Clinical Trial
PSD502 in Subjects With Premature Ejaculation
Status: Enrolling, Phase II
Updated: 12/31/1969
Regional Urology
mi
from
Shreveport, LA
Click here to add this to my saved trials
Clinical Trial
OKS for Gait Instability
Status: Enrolling
Updated: 12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Adavosertib With or Without Olaparib in Treating Participants With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Clostridium Difficile Associated Disease Clinical Trial
Evaluation Of Clostridium Difficile Vaccine Lot Consistency In Healthy Adults 65 To 85 Years Of Age
Status: Enrolling, Phase III
Updated: 12/31/1969
Meridian Clinical Research
mi
from
Norfolk, NE
Click here to add this to my saved trials
Clostridium Difficile Associated Disease Clinical Trial
Evaluation Of Clostridium Difficile Vaccine Lot Consistency In Healthy Adults 65 To 85 Years Of Age
Status: Enrolling, Phase III
Updated: 12/31/1969
PMG Research of Wilmington
mi
from
Wilmington, NC
Click here to add this to my saved trials
Presbycusis Clinical Trial
Cost-effective Hearing Aid Delivery Models
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Catheter-Related Infections Clinical Trial
Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Georgetown University- Lombardi Comprehensive Cancer Center
mi
from
Washington DC,
Click here to add this to my saved trials
Amyotrophic Lateral Sclerosis Clinical Trial
Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS
Status: Enrolling, Phase III
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Amyotrophic Lateral Sclerosis Clinical Trial
Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS
Status: Enrolling, Phase III
Updated: 12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Amyotrophic Lateral Sclerosis Clinical Trial
Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS
Status: Enrolling, Phase III
Updated: 12/31/1969
Nerve and Muscle Center of Texas
mi
from
Houston, TX
Click here to add this to my saved trials
Amyotrophic Lateral Sclerosis Clinical Trial
Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS
Status: Enrolling, Phase III
Updated: 12/31/1969
Froedtert Hospital
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Amyotrophic Lateral Sclerosis Clinical Trial
Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Utah Imaging and Neurosciences Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Amyotrophic Lateral Sclerosis Clinical Trial
Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS
Status: Enrolling, Phase III
Updated: 12/31/1969
California Pacific Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
A Study Exploring the Safety and Tolerability of INCB081776 in Participants With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Sarah Cannon Research Institute
mi
from
Nashville, TN
Click here to add this to my saved trials
Psoriasis Clinical Trial
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
Status: Enrolling, Phase III
Updated: 12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Psoriasis Clinical Trial
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
Status: Enrolling, Phase III
Updated: 12/31/1969
David Stoll, MD
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Psoriasis Clinical Trial
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
Status: Enrolling, Phase III
Updated: 12/31/1969
Modern Research Associates
mi
from
Dallas, TX
Click here to add this to my saved trials
Psoriasis Clinical Trial
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
Status: Enrolling, Phase III
Updated: 12/31/1969
Dawes Fretzin Clinical Research
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Psoriasis Clinical Trial
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Partners, LLC
mi
from
Johnston, RI
Click here to add this to my saved trials
Psoriasis Clinical Trial
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
Status: Enrolling, Phase III
Updated: 12/31/1969
Keck School of Medicine - University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Psoriasis Clinical Trial
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
Status: Enrolling, Phase III
Updated: 12/31/1969
Mount Sinai School of Medicine Dermatology Clinical Trials
mi
from
New York, NY
Click here to add this to my saved trials
Psoriasis Clinical Trial
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
Status: Enrolling, Phase III
Updated: 12/31/1969
Park Avenue Dermatology
mi
from
Orange Park, FL
Click here to add this to my saved trials
Psoriasis Clinical Trial
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Psoriasis Clinical Trial
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
Status: Enrolling, Phase III
Updated: 12/31/1969
Southern California Dermatology, Inc.
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Wilson Disease Clinical Trial
Trientine Tetrahydrochloride (TETA 4HCL) for the Treatment of Wilson's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
A Study of ASP1948, Targeting an Immune Modulatory Receptor, in Subjects With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Comprehensive Cancer Centers of Nevada
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
A Study of ASP1948, Targeting an Immune Modulatory Receptor, in Subjects With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Washington/Seattle Cancer Care Alliance
mi
from
Seattle, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Emory University Hospital-Winship Cancer Institute
mi
from
Atlanta, GA
Click here to add this to my saved trials
Oncology Clinical Trial
Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Mayo Clinic Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Myasthenia Gravis, MuSK Clinical Trial
Long Term Safety Study of Amifampridine Phosphate in MuSK-MG (Muscle Specific Tyrosine Kinase Myasthenia Gravis)
Status: Enrolling, Phase III
Updated: 12/31/1969
Wayne State University
mi
from
Detroit, MI
Click here to add this to my saved trials
End Stage Liver Disease Clinical Trial
Pilot Study of the Liver Live Donor Champion Program
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Nicotine Dependence Clinical Trial
Evaluation of Very Low Nicotine Content Cigarettes in Adolescent Smokers
Status: Enrolling
Updated: 12/31/1969
Brown University School of Public Health
mi
from
Providence, RI
Click here to add this to my saved trials
Neurology, Oncology, Orthopedics / Podiatry, Other Clinical Trial
Study of Aspirin in Patients With Vestibular Schwannoma
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Neurology, Oncology, Orthopedics / Podiatry, Other Clinical Trial
Study of Aspirin in Patients With Vestibular Schwannoma
Status: Enrolling, Phase II
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Cognitive Dysfunction Clinical Trial
PREsurgical Cognitive Evaluation Via Digital clockfacEdrawing
Status: Enrolling, Phase
Updated: 12/31/1969
UF Health
mi
from
Gainesville, FL
Click here to add this to my saved trials
Glottic Carcinoma Clinical Trial
Stereotactic Ablative Radiotherapy for Early-stage Glottic Larynx Cancer
Status: Enrolling
Updated: 12/31/1969
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
Postural Control Under Different Cognitive Loads in Adult Survivors of Acute Lymphoblastic Leukemia and Age-Matched Healthy Individuals
Status: Enrolling, Phase
Updated: 12/31/1969
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Musculoskeletal Clinical Trial
Spinal Manipulation and Patient Self-Management for Preventing Acute to Chronic Back Pain
Status: Enrolling, Phase III
Updated: 12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Radiation Therapy, and Temozolomide in Treating Participants With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600E Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Radiation Therapy, and Temozolomide in Treating Participants With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600E Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Radiation Therapy, and Temozolomide in Treating Participants With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600E Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
Children's Hospital Medical Center of Akron
mi
from
Akron, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Radiation Therapy, and Temozolomide in Treating Participants With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600E Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
Albany Medical Center
mi
from
Albany, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Radiation Therapy, and Temozolomide in Treating Participants With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600E Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Radiation Therapy, and Temozolomide in Treating Participants With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600E Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Radiation Therapy, and Temozolomide in Treating Participants With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600E Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
Arkansas Children's Hospital
mi
from
Little Rock, AR
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Radiation Therapy, and Temozolomide in Treating Participants With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600E Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
Miller Children's and Women's Hospital Long Beach
mi
from
Long Beach, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Radiation Therapy, and Temozolomide in Treating Participants With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600E Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
Mattel Children's Hospital at UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Radiation Therapy, and Temozolomide in Treating Participants With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600E Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
West Virginia University Healthcare
mi
from
Morgantown, WV
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Radiation Therapy, and Temozolomide in Treating Participants With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600E Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Radiation Therapy, and Temozolomide in Treating Participants With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600E Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
Arnold Palmer Hospital for Children
mi
from
Orlando, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Radiation Therapy, and Temozolomide in Treating Participants With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600E Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Radiation Therapy, and Temozolomide in Treating Participants With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600E Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
Primary Children's Hospital
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Radiation Therapy, and Temozolomide in Treating Participants With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600E Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
Mary Bridge Children's Hospital and Health Center
mi
from
Tacoma, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Radiation Therapy, and Temozolomide in Treating Participants With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600E Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
Univ of Massachusetts Med School
mi
from
Worcester, MA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
VITROS Immunodiagnostic Products hs Troponin I
Status: Enrolling, Phase
Updated: 12/31/1969
Chandler Regional Medical Center
mi
from
Chandler, AZ
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
VITROS Immunodiagnostic Products hs Troponin I
Status: Enrolling, Phase
Updated: 12/31/1969
Wayne State University/Detroit Receiving Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Marfan Syndrome Clinical Trial
Tele-Clinic Visits in Pediatric Marfan Patients Using Parental Echo: The Future?
Status: Enrolling
Updated: 12/31/1969
Lucile Packard Children's Hospital
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Parkinson Disease Clinical Trial
Longitudinal Outcomes of DBS in PD
Status: Enrolling, Phase
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Renal Colic Clinical Trial
Lidocaine vs Ketorolac for Management of Renal Colic in the Emergency Department
Status: Enrolling, Phase IV
Updated: 12/31/1969
Brooklyn Hospital Center
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Blepharoptosis Clinical Trial
Study of Safety and Efficacy of RVL-1201 in the Treatment of Blepharoptosis
Status: Enrolling, Phase III
Updated: 12/31/1969
Sarasota Retina Institute
mi
from
Sarasota, FL
Click here to add this to my saved trials
Blepharoptosis Clinical Trial
Study of Safety and Efficacy of RVL-1201 in the Treatment of Blepharoptosis
Status: Enrolling, Phase III
Updated: 12/31/1969
Comprehensive Eye Care Ltd
mi
from
Washington, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate
Status: Enrolling, Phase I
Updated: 12/31/1969
UCLA Jonsson Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Hypotension and Shock Clinical Trial
Measurement of Hemodynamic Responses to Lower Body Negative Pressure
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Oncology Clinical Trial
CVM-1118 and Sorafenib Combination in Subjects With Advanced Hepatocellular Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Charleston Hematology/Oncology Associates, Pa
mi
from
Charleston, SC
Click here to add this to my saved trials
Oncology Clinical Trial
CVM-1118 and Sorafenib Combination in Subjects With Advanced Hepatocellular Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Innovative Clinical Research Institute, LLC
mi
from
Whittier, CA
Click here to add this to my saved trials
Stenosing Tenosynovitis Clinical Trial
Corticosteroid vs. Amniotic Fluid Injections in Patients With Trigger Finger
Status: Enrolling, Phase III
Updated: 12/31/1969
Athens Orthopedic Clinic, PA
mi
from
Athens, GA
Click here to add this to my saved trials
Alcohol Drinking Clinical Trial
Evaluating Within-Person and Between-Person Effects Of A Personalized Normative Feedback Intervention On Drinking As They Are Moderated By Self-Determination
Status: Enrolling
Updated: 12/31/1969
University of Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Achondroplasia Clinical Trial
A Clinical Trial to Evaluate the Safety and Efficacy of BMN 111 in Infants and Young Children With Achondroplasia
Status: Enrolling, Phase II
Updated: 12/31/1969
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Asthma in Children Clinical Trial
Rhode Island Asthma Integrated Response Program
Status: Enrolling
Updated: 12/31/1969
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Psychiatry / Psychology, Pulmonary / Respiratory Diseases Clinical Trial
Safety, Tolerability, PK Profile, and Symptom Response of a 7-Day Dosing With 25 mg Daily and 50 mg Daily of REL-1017 in Major Depressive Disorder
Status: Enrolling, Phase II
Updated: 12/31/1969
Woodland International Research Group, Inc.
mi
from
Little Rock, AR
Click here to add this to my saved trials
Cirrhosis, Liver Clinical Trial
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
The Value of CT-FFR Compared to CCTA or CCTA and Stress MPI in Low to Intermediate Risk ED Patients With Toshiba CT-FFR
Status: Enrolling
Updated: 12/31/1969
North Shore University Hospital
mi
from
Manhasset, NY
Click here to add this to my saved trials
Child Development Clinical Trial
Growth and Tolerance of Infants Fed Formula for 16 Weeks
Status: Enrolling
Updated: 12/31/1969
Aventiv Research
mi
from
Columbus, OH
Click here to add this to my saved trials